Validation of hair ethyl glucuronide using transdermal monitoring and self-reported alcohol use in women of childbearing potential.
alcohol
biosensor
ethyl glucuronide
hair EtG
transdermal
Journal
Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
15
10
2020
received:
24
07
2020
accepted:
05
11
2020
pubmed:
3
3
2021
medline:
12
2
2022
entrez:
2
3
2021
Statut:
ppublish
Résumé
The present study aimed to evaluate the validity of hair ethyl glucuronide concentrations compared with transdermal alcohol concentration and self-reported alcohol use. This trial included 25 adolescent and young adult females, aged 16-24, who reported at least one heavy drinking episode (≥4 drinks) in the two weeks prior to baseline. All participants were asked to wear an alcohol biosensor over a one-month prospective study. Detailed self-report of drinking behaviors was assessed weekly. Estimates of blood alcohol concentration were computed from self-report data using the National Highway and Transportation Safety Administration equation. Transdermal alcohol concentration and estimated blood alcohol concentration data were categorized into at-risk (>0.05 g/dL alcohol) and high-risk (>0.08 g/dL alcohol) drinking events. Hair ethyl glucuronide concentration, total number of drinking events, moderate (>0.05 g/dL) and high level (>0.08 g/dL) of transdermal alcohol concentration, and estimated blood alcohol concentration drinking events were analyzed with Spearman's rank correlation test for validity comparisons. No significant correlations were found between hair ethyl glucuronide values and total number, and moderate or high levels of detected drinking events by estimated blood alcohol concentration or transdermal alcohol concentration. Total number of drinking events detected and number of drinking events >0.08 g/dL using estimated blood alcohol concentration and transdermal alcohol concentration methods were significantly correlated with each other (respectively, R = .33, P < .05; R = .42, P < .05). Our findings indicate that, due to the number of false negatives, hair ethyl glucuronide concentrations should be used with caution for monitoring abstinence from alcohol use.
Identifiants
pubmed: 33650766
doi: 10.1002/npr2.12151
pmc: PMC8340845
doi:
Substances chimiques
Biomarkers
0
Blood Alcohol Content
0
Glucuronates
0
ethyl glucuronide
17685-04-0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
144-151Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM109097
Pays : United States
Informations de copyright
© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Society of Neuropsychopharmacology.
Références
Ther Drug Monit. 2008 Apr;30(2):255-63
pubmed: 18367991
Addiction. 2009 Jun;104(6):915-20
pubmed: 19392911
BMJ Open. 2016 Oct 24;6(10):e011827
pubmed: 27797998
Addiction. 2011 Jul;106(7):1221-7
pubmed: 21205054
Alcohol Alcohol. 2012 Mar-Apr;47(2):127-32
pubmed: 22162917
Br J Addict. 1988 Sep;83(9):1019-30
pubmed: 3066418
Alcohol Alcohol Suppl. 2006 Oct-Nov;41(1):i3-7
pubmed: 17030501
Drug Test Anal. 2014 Jun;6 Suppl 1:74-7
pubmed: 24817051
Addiction. 2014 Mar;109(3):425-31
pubmed: 24524319
Am J Public Health. 2015 Jun;105(6):1120-7
pubmed: 25905846
Drug Alcohol Depend. 2014 Aug 1;141:163-6
pubmed: 24928477
Am J Prev Med. 1999 Aug;17(2):101-7
pubmed: 10490051
Forensic Sci Int. 2002 Aug 14;128(1-2):59-65
pubmed: 12208024
Drug Alcohol Depend. 2014 Jan 1;134:1-11
pubmed: 24239414
Forensic Sci Int. 2010 Mar 20;196(1-3):101-10
pubmed: 20061103
Alcohol Clin Exp Res. 2006 Jan;30(1):26-33
pubmed: 16433729
Alcohol Alcohol. 2007 Jul-Aug;42(4):326-7
pubmed: 17517821
Addiction. 2003 Dec;98 Suppl 2:51-61
pubmed: 14984242
Alcohol Clin Exp Res. 1992 Aug;16(4):721-5
pubmed: 1530135
Anal Bioanal Chem. 2016 Mar;408(8):2019-25
pubmed: 26549114
Alcohol Clin Exp Res. 2009 Apr;33(4):703-11
pubmed: 19170663
Psychol Assess. 2009 Dec;21(4):486-97
pubmed: 19947783
Alcohol Alcohol. 2000 May-Jun;35(3):283-5
pubmed: 10869249
Drug Alcohol Depend. 2011 Nov 1;118(2-3):391-9
pubmed: 21665385
Int J Legal Med. 2012 Mar;126(2):243-50
pubmed: 21910015
Alcohol Alcohol. 2012 May-Jun;47(3):267-72
pubmed: 22336766
Neuropsychopharmacol Rep. 2021 Jun;41(2):144-151
pubmed: 33650766
Psychol Assess. 2009 Dec;21(4):457-62
pubmed: 19947780
Alcohol Clin Exp Res. 2013 Jan;37(1):16-22
pubmed: 22823467
Addiction. 2006 Oct;101(10):1408-12
pubmed: 16968341
Methods Find Exp Clin Pharmacol. 1985 May;7(5):269-74
pubmed: 4033304
Alcohol Alcohol. 2013 Sep-Oct;48(5):558-63
pubmed: 23813296
Anal Bioanal Chem. 2012 May;403(3):769-76
pubmed: 22451175
Forensic Sci Int. 2007 Oct 2;172(1):23-7
pubmed: 17184945
Alcohol Alcohol. 2000 May-Jun;35(3):313-4
pubmed: 10869254
Rapid Commun Mass Spectrom. 2005;19(10):1321-31
pubmed: 15841501
Forensic Sci Int. 2007 Jul 4;169(2-3):129-36
pubmed: 16963215
Forensic Sci Int. 2007 Dec 20;173(2-3):87-92
pubmed: 17337139
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Addict Disord Their Treat. 2015 Sep;14(3):124-130
pubmed: 26500459
Alcohol Alcohol. 2013 Jan-Feb;48(1):83-7
pubmed: 23015609
Clin Gastroenterol Hepatol. 2018 Mar;16(3):454-456
pubmed: 28830836
Addict Behav. 2015 Nov;50:205-12
pubmed: 26160523
MMWR Surveill Summ. 2018 Jun 15;67(8):1-114
pubmed: 29902162
Addiction. 2003 Dec;98 Suppl 2:1-12
pubmed: 14984237
Drug Alcohol Depend. 2014 Sep 1;142:301-6
pubmed: 25064019
J Stud Alcohol. 2002 Nov;63(6):762-6
pubmed: 12529077
Forensic Sci Med Pathol. 2007 Mar;3(1):33-9
pubmed: 25868887